Authors:
VIVIANI S
CAMERINI E
BONFANTE V
SANTORO A
BALZAROTTI M
FORNIER M
DEVIZZI L
VERDERIO P
VALAGUSSA P
BONADONNA G
Citation: S. Viviani et al., SOLUBLE INTERLEUKIN-2 RECEPTORS (SIL-2R) IN HODGKINS-DISEASE - OUTCOME AND CLINICAL IMPLICATIONS, British Journal of Cancer, 77(6), 1998, pp. 992-997
Authors:
TONDINI C
BALZAROTTI M
SANTORO A
ZANINI M
FORNIER M
GIARDINI R
DEFELICE G
BOZZETTI F
BONADONNA G
Citation: C. Tondini et al., INITIAL CHEMOTHERAPY FOR PRIMARY RESECTABLE LARGE-CELL LYMPHOMA OF THE STOMACH, Annals of oncology, 8(5), 1997, pp. 497-499
Authors:
BONFANTE V
SANTORO A
VIVIANI S
DEVIZZI L
BALZAROTTI M
SONCINI F
ZANINI M
VALAGUSSA P
BONADONNA G
Citation: V. Bonfante et al., OUTCOME OF PATIENTS WITH HODGKINS-DISEASE FAILING AFTER PRIMARY MOPP-ABVD, Journal of clinical oncology, 15(2), 1997, pp. 528-534
Authors:
TONDINI C
BALZAROTTI M
RAMPINELLI I
LUONI M
DEPAOLI A
VALAGUSSA P
SANTORO A
BAJETTA E
BONADONNA G
BREGNI M
Citation: C. Tondini et al., RANDOMIZED PHASE-II EVALUATION OF FLUDARABINE (RDA) AND 2-CHLOREDEOSSIADENOSINE (CDA) IN THE TREATMENT OF RELAPSED REFRACTORY LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) AND CLL/, Blood, 90(10), 1997, pp. 1532-1532
Authors:
TONDINI C
GIARDINI R
BOZZETTI F
VALAGUSSA P
SANTORO A
BERTULLI R
BALZAROTTI M
ROCCA A
LOMBARDI F
FERRERI AJM
BONADONNA G
Citation: C. Tondini et al., COMBINED-MODALITY TREATMENT FOR PRIMARY GASTROINTESTINAL NON-HODGKINS-LYMPHOMA - THE MILAN CANCER INSTITUTE EXPERIENCE, Annals of oncology, 4(10), 1993, pp. 831-837
Authors:
PELLEGRIS G
LOMBARDO C
CANTONI A
DEVIZZI L
BALZAROTTI M
Citation: G. Pellegris et al., STUDY OF THE HLA-DP-BETA-1 LOCUS BY THE POLYMERASE CHAIN-REACTION TECHNIQUE IN PATIENTS WITH HODGKINS-DISEASE, Tumori, 79(2), 1993, pp. 133-136